- Home
- Publications
- Publication Search
- Publication Details
Title
The role of the LRRK2 gene in Parkinsonism
Authors
Keywords
LRRK2, Parkinsonism, Pathology, Clinical features, Pathogenic mechanism
Journal
Molecular Neurodegeneration
Volume 9, Issue 1, Pages 47
Publisher
Springer Nature
Online
2014-11-13
DOI
10.1186/1750-1326-9-47
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LRRK2, but not pathogenic mutants, protects against H2O2 stress depending on mitochondrial function and endocytosis in a yeast model
- (2014) Clara Pereira et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila
- (2014) D. C. Angeles et al. HUMAN MOLECULAR GENETICS
- Mutant LRRK2 Toxicity in Neurons Depends on LRRK2 Levels and Synuclein But Not Kinase Activity or Inclusion Bodies
- (2014) G. Skibinski et al. JOURNAL OF NEUROSCIENCE
- Structural and functional in silico analysis of LRRK2 missense substitutions
- (2014) Fernando Cardona et al. MOLECULAR BIOLOGY REPORTS
- Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S
- (2013) Min Liu et al. BIOCHEMISTRY
- Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β
- (2013) Fumitaka Kawakami et al. FEBS Journal
- A Direct Interaction between Leucine-rich Repeat Kinase 2 and Specific β-Tubulin Isoforms Regulates Tubulin Acetylation
- (2013) Bernard M. H. Law et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ATP-competitive LRRK2 inhibitors interfere with monoclonal antibody binding to the kinase domain of LRRK2 under native conditions. A method to directly monitor the active conformation of LRRK2?
- (2013) Frank Gillardon et al. JOURNAL OF NEUROSCIENCE METHODS
- A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism
- (2013) Joanne Trinh et al. NEUROBIOLOGY OF AGING
- The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease
- (2013) Hardy J. Rideout et al. NEUROCHEMICAL RESEARCH
- Development of Inducible Leucine-rich Repeat Kinase 2 (LRRK2) Cell Lines for Therapeutics Development in Parkinson’s Disease
- (2013) Liang Huang et al. Neurotherapeutics
- The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease
- (2013) Lior Greenbaum et al. PARKINSONISM & RELATED DISORDERS
- Non-Motor and Motor Features in LRRK2 Transgenic Mice
- (2013) Zoë Bichler et al. PLoS One
- α-Synuclein oligomers and clinical implications for Parkinson disease
- (2012) Lorraine V. Kalia et al. ANNALS OF NEUROLOGY
- The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts
- (2012) José M. Bravo-San Pedro et al. Autophagy
- LRRK2 as a modulator of lysosomal calcium homeostasis with downstream effects on autophagy
- (2012) Patricia Gómez-Suaga et al. Autophagy
- Genetic analysis of Parkinson's disease-linked leucine-rich repeat kinase 2
- (2012) Youren Tong et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
- (2012) José M. Bravo-San Pedro et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
- (2012) Adriana Sánchez-Danés et al. EMBO Molecular Medicine
- Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity
- (2012) C. Yao et al. HUMAN MOLECULAR GENETICS
- LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
- (2012) Patrícia Silva Guerreiro et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein
- (2012) Jingwen Niu et al. JOURNAL OF NEUROCHEMISTRY
- Development and Characterization of a New Parkinson's Disease Model Resulting from Impaired Autophagy
- (2012) I. Ahmed et al. JOURNAL OF NEUROSCIENCE
- LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
- (2012) M. S. Moehle et al. JOURNAL OF NEUROSCIENCE
- Disrupted Autophagy Leads to Dopaminergic Axon and Dendrite Degeneration and Promotes Presynaptic Accumulation of -Synuclein and LRRK2 in the Brain
- (2012) L. G. Friedman et al. JOURNAL OF NEUROSCIENCE
- LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth
- (2012) Fumitaka Kawakami et al. PLoS One
- Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia
- (2012) Beomsue Kim et al. PLoS One
- Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson’s Disease-Related Toxicity in Human Neurons
- (2011) Nigel Ramsden et al. ACS Chemical Biology
- Parkinson's Disease: Genetics and Pathogenesis
- (2011) Joshua M. Shulman et al. Annual Review of Pathology-Mechanisms of Disease
- α-Synuclein Aggregation and Transmission Are Enhanced by Leucine-Rich Repeat Kinase 2 in Human Neuroblastoma SH-SY5Y Cells
- (2011) Kazunari Kondo et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Expression of leucine-rich repeat kinase 2 (LRRK2) inhibits the processing of uMtCK to induce cell death in a cell culture model system
- (2011) Jie Cui et al. BIOSCIENCE REPORTS
- Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning
- (2011) M. W. Dodson et al. HUMAN MOLECULAR GENETICS
- Mutations inLRRK2increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death
- (2011) Dario C. Angeles et al. HUMAN MUTATION
- Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
- (2011) Mansoureh Hakimi et al. JOURNAL OF NEURAL TRANSMISSION
- LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool
- (2011) G. Piccoli et al. JOURNAL OF NEUROSCIENCE
- Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers
- (2011) Kathrin Brockmann et al. MOVEMENT DISORDERS
- Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease
- (2011) Vicki Shanker et al. MOVEMENT DISORDERS
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
- (2011) Zhihua Liu et al. NATURE IMMUNOLOGY
- Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson’s disease
- (2011) Soraya Bardien et al. PARKINSONISM & RELATED DISORDERS
- Lysosomal membrane permeabilization in Parkinson disease
- (2010) Miquel Vila et al. Autophagy
- LRRK2 Is Involved in the IFN- Response and Host Response to Pathogens
- (2010) A. Gardet et al. JOURNAL OF IMMUNOLOGY
- Pathogenic Lysosomal Depletion in Parkinson's Disease
- (2010) B. Dehay et al. JOURNAL OF NEUROSCIENCE
- Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model
- (2010) Ann E. Kingsbury et al. MOVEMENT DISORDERS
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
- (2010) Mark R. Cookson NATURE REVIEWS NEUROSCIENCE
- LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
- (2010) Chen Yao et al. NEUROBIOLOGY OF DISEASE
- Synaptic dysfunction in genetic models of Parkinson's disease: A role for autophagy?
- (2010) Edward D. Plowey et al. NEUROBIOLOGY OF DISEASE
- Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
- (2010) H. Mortiboys et al. NEUROLOGY
- LRRK2 and neurodegeneration
- (2009) Gabriel Santpere et al. ACTA NEUROPATHOLOGICA
- Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
- (2009) Hong Qing et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
- (2009) G. Cuny CURRENT PHARMACEUTICAL DESIGN
- Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options
- (2009) A. C. Ludolph et al. EUROPEAN JOURNAL OF NEUROLOGY
- LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity
- (2009) Hye Young Heo et al. EXPERIMENTAL CELL RESEARCH
- LRRK2 in Parkinson’s disease: biochemical functions
- (2009) Vasanti S. Anand et al. FEBS Journal
- LRRK2 in Parkinson’s disease: genetic and clinical studies from patients
- (2009) Udhaya Kumari et al. FEBS Journal
- Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease
- (2009) K. Venderova et al. HUMAN MOLECULAR GENETICS
- LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model
- (2009) Javier Alegre-Abarrategui et al. HUMAN MOLECULAR GENETICS
- Abnormal Localization of Leucine-Rich Repeat Kinase 2 to the Endosomal-Lysosomal Compartment in Lewy Body Disease
- (2009) Shinji Higashi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis
- (2009) L. Parisiadou et al. JOURNAL OF NEUROSCIENCE
- Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila
- (2009) C.-H. Ng et al. JOURNAL OF NEUROSCIENCE
- LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans
- (2009) S. Saha et al. JOURNAL OF NEUROSCIENCE
- LRRK2R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China
- (2009) Zijuan Zhang et al. MOVEMENT DISORDERS
- Neuropathology of Parkinson's disease with the R1441G mutation inLRRK2
- (2009) José-Félix Martí-Massó et al. MOVEMENT DISORDERS
- Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
- (2009) Yanping Li et al. NATURE NEUROSCIENCE
- Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
- (2009) Xian Lin et al. NEURON
- The WD40 Domain Is Required for LRRK2 Neurotoxicity
- (2009) Nathan D. Jorgensen et al. PLoS One
- R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
- (2009) Y. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autophagy: Principles and significance in health and disease
- (2008) Virginia Todde et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Targets for neuroprotection in Parkinson's disease
- (2008) Talene A. Yacoubian et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Proteomics of the lysosome
- (2008) Torben Lübke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Ancient Origin of the Parkinson Disease Gene LRRK2
- (2008) Ignacio Marín JOURNAL OF MOLECULAR EVOLUTION
- Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
- (2008) Edward D. Plowey et al. JOURNAL OF NEUROCHEMISTRY
- Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
- (2008) James B Koprich et al. Journal of Neuroinflammation
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- Investigating Convergent Actions of Genes Linked to Familial Parkinson’s Disease
- (2008) Benjamin Wolozin et al. Neurodegenerative Diseases
- MIXED LINEAGE KINASE INHIBITOR CEP- 1347 FAILS TO DELAY DISABILITY IN EARLY PARKINSON DISEASE
- (2008) L. H. Wang et al. NEUROLOGY
- Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
- (2008) K. Haugarvoll et al. NEUROLOGY
- Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism
- (2008) Owen A. Ross et al. PARKINSONISM & RELATED DISORDERS
- Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes
- (2008) Kazuko Hasegawa et al. PARKINSONISM & RELATED DISORDERS
- A Drosophila model for LRRK2-linked parkinsonism
- (2008) Z. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation